Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Repros Therapeutics (RPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,110
  • Shares Outstanding, K 39,560
  • Annual Sales, $ 50 K
  • Annual Income, $ -17,270 K
  • 36-Month Beta 0.45
  • Price/Sales 673.54
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.50
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.60 +10.00%
on 12/18/17
0.67 -1.49%
on 01/05/18
unch (unch)
since 12/15/17
3-Month
0.36 +83.33%
on 11/09/17
0.68 -2.94%
on 12/12/17
+0.20 (+41.94%)
since 10/17/17
52-Week
0.26 +153.85%
on 08/22/17
1.55 -57.42%
on 01/30/17
-0.69 (-51.11%)
since 01/17/17

Most Recent Stories

More News
Lifshitz & Miller LLP Announces Investigation of Almost Family, Inc., FNB Bancorp, Repros Therapeutics Inc., Snyder's-Lance, Inc., Southcross Energy Partners, L.P., Stone Energy Corporation and Tableau Software, Inc.

Almost Family, Inc. (AFAM)

SXE : 1.99 (+3.11%)
RPRX : 0.66 (unch)
LHCG : 65.86 (+1.54%)
SGY : 37.77 (+6.04%)
DATA : 74.07 (+1.19%)
LNCE : 50.06 (+0.04%)
FNBG : 37.89 (+0.69%)
AFAM : 59.75 (+1.01%)
Biotech Stocks' Research Reports Released on Repros Therapeutics, Aldeyra Therapeutics, Neothetics, and BioLine Rx

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on RPRX, ALDX, NEOT, and BLRX which can be accessed for free by signing up to www.wallstequities.com/registration....

ALDX : 6.65 (+0.76%)
RPRX : 0.66 (unch)
NEOT : 1.92 (+4.35%)
BLRX : 1.06 (-1.85%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Repros Therapeutics, Inc. - RPRX

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Repros Therapeutics,...

RPRX : 0.66 (unch)
AGN : 176.72 (-1.09%)
Repros Therapeutics Inc.(R) Receives Feedback Following an Oral Explanation with the European Medicines Agency

Repros Therapeutics Inc. (NASDAQ:RPRX) ("Repros" or the "Company") today announced that following an Oral Explanation, it has received feedback that a negative opinion is likely to be received in January...

RPRX : 0.66 (unch)
Allergan Inks Deal to Buy Texas-Based Repros Therapeutics

Allergan (AGN) signs a definitive contract to acquire Texas-based Repros Therapeutics, which is focused on developing new drugs to treat hormonal and reproductive system disorders.

CORT : 22.19 (+4.13%)
RPRX : 0.66 (unch)
ACHN : 2.90 (-1.02%)
AGN : 176.72 (-1.09%)
REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Rigrodsky & Long, P.A.:

RPRX : 0.66 (unch)
AGN : 176.72 (-1.09%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

RPRX : 0.66 (unch)
AGN : 176.72 (-1.09%)
Repros Therapeutics Inc.(R) Announces Acquisition by Allergan plc

Repros Therapeutics Inc. (NASDAQ:RPRX) ("Repros" or the "Company") today announced that it has entered into a definitive agreement under which Allergan plc ("Allergan"), through a subsidiary, will acquire...

RPRX : 0.66 (unch)
AGN : 176.72 (-1.09%)
Today's Research Reports on Trending Tickers: Incyte Corporation and Repros Therapeutics Inc.

NEW YORK, NY / ACCESSWIRE / November 21, 2017 / U.S. markets edged higher Monday as investors focus shifted back towards corporate earnings and potential tax cuts. The Dow Jones Industrial Average gained...

RPRX : 0.66 (unch)
INCY : 90.31 (-1.46%)
Repros Therapeutics Inc.(R) Reports Third Quarter 2017 Financial Results

Repros Therapeutics Inc.(R) (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2017.

RPRX : 0.66 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Zonagen Inc. is a biopharmaceutical company engaged in the development of products for the human reproductive system, including sexual dysfunction, vaccine adjuvants, products for fertility and female health as well as urological applications, specifically prostate cancer. Zonagen's products to treat...

See More

Key Turning Points

2nd Resistance Point 0.66
1st Resistance Point 0.66
Last Price 0.66
1st Support Level 0.66
2nd Support Level 0.66

See More

52-Week High 1.55
Fibonacci 61.8% 1.06
Fibonacci 50% 0.90
Fibonacci 38.2% 0.75
Last Price 0.66
52-Week Low 0.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.